FDA Warning: Smoking Cessation Meds
July 1, 2009 by Marijke Durning, RN
Filed under Diseases & Conditions
The stop-smoking market is huge, from the do-it-yourself treatments to alternative medicine to pharmaceutical medicines. Over the past few years, medications like Chantix (varenicline) and Zyban and Wellbutrin (buproprion) have been used by many people, some successfully, some not.
One problem with these medications is that they seem to have an adverse effect on some people who take them and these can be quite serious. According to a press release issued by the FDA:
These symptoms include changes in behavior, hostility, agitation, depressed mood, suicidal thoughts and behavior, and attempted suicide.
Now, the FDA has told the manufacture
rs that they must add new warnings, called Box Warning and develop patient medication guides that outline these risks.
Here is more from the release:
Healthcare professionals should advise patients to stop taking varenicline or bupropion and contact a healthcare provider immediately if they experience agitation, depressed mood, and any changes in behavior that are not typical of nicotine withdrawal, or if they experience suicidal thoughts or behavior.
If you take any of these medications and you have any concerns, please speak with your doctor.
~~~~
Image courtesy PhotoXpress.com














